{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T16:17:59Z","timestamp":1648570679446},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00105-020-04704-1","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T15:03:19Z","timestamp":1602514999000},"page":"525-527","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alopecia areata mit gutem Ansprechen auf Tofacitinib"],"prefix":"10.1007","volume":"72","author":[{"given":"A.","family":"Maksimow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Stintzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wohlrab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"4704_CR1","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1038\/ncomms6966","volume":"6","author":"RC Betz","year":"2015","unstructured":"Betz\u00a0RC, Petukhova\u00a0L, Ripke\u00a0S et al (2015) Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun 6:5966","journal-title":"Nat Commun"},{"key":"4704_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdermsci.2015.01.004","volume":"78","author":"R Biran","year":"2015","unstructured":"Biran\u00a0R, Zlotogorski\u00a0A, Ramot\u00a0Y (2015) The genetics of alopecia areata: new approaches, new findings, new treatments. J\u00a0Dermatol Sci 78:11\u201320","journal-title":"J Dermatol Sci"},{"key":"4704_CR3","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1038\/jid.2014.260","volume":"134","author":"BG Craiglow","year":"2014","unstructured":"Craiglow\u00a0BG, King\u00a0BA (2014) Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a\u00a0patient with plaque psoriasis. J\u00a0Invest Dermatol 134:2988\u20132990","journal-title":"J Invest Dermatol"},{"key":"4704_CR4","doi-asserted-by":"publisher","first-page":"e13053","DOI":"10.1111\/dth.13053","volume":"32","author":"AB De Oliveira","year":"2019","unstructured":"De Oliveira\u00a0AB, Alpalhao\u00a0M, Filipe\u00a0P et\u00a0al (2019) The role of Janus kinase inhibitors in the treatment of alopecia areata: a systematic review. Dermatol Ther 32:e13053","journal-title":"Dermatol Ther"},{"key":"4704_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jdv.15937","volume":"34","author":"L Guo","year":"2020","unstructured":"Guo\u00a0L, Feng\u00a0S, Sun\u00a0B et al (2020) Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a\u00a0systemic review and meta-analysis. J\u00a0Eur Acad Dermatol Venereol 34:192\u2013201","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4704_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1365-2230.2002.01077.x","volume":"27","author":"AJ Mcdonagh","year":"2002","unstructured":"Mcdonagh\u00a0AJ, Tazi-Ahnini\u00a0R (2002) Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 27:405\u2013409","journal-title":"Clin Exp Dermatol"},{"key":"4704_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/ijt.ijt_76_19","volume":"11","author":"K Migacz-Gruszka","year":"2019","unstructured":"Migacz-Gruszka\u00a0K, Branicki\u00a0W, Obtulowicz\u00a0A et al (2019) What\u2019s new in the pathophysiology of alopecia areata? The possible contribution of skin and gut microbiome in the pathogenesis of alopecia\u2014big opportunities, big challenges, and novel perspectives. Int J Trichology 11:185\u2013188","journal-title":"Int J Trichology"},{"key":"4704_CR8","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/jidsymp.2013.7","volume":"16","author":"R Paus","year":"2013","unstructured":"Paus\u00a0R, Bertolini\u00a0M (2013) The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives. J\u00a0Investig Dermatol Symp Proc 16:S25\u201327","journal-title":"J Investig Dermatol Symp Proc"},{"key":"4704_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/JID.2015.402","volume":"136","author":"L Petukhova","year":"2016","unstructured":"Petukhova\u00a0L, Christiano\u00a0AM (2016) Functional interpretation of genome-wide association study evidence in alopecia areata. J\u00a0Invest Dermatol 136:314\u2013317","journal-title":"J Invest Dermatol"},{"key":"4704_CR10","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3389\/fimmu.2019.02847","volume":"10","author":"F Solimani","year":"2019","unstructured":"Solimani\u00a0F, Meier\u00a0K, Ghoreschi\u00a0K (2019) Emerging topical and systemic JAK inhibitors in dermatology. Front Immunol 10:2847","journal-title":"Front Immunol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04704-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-020-04704-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04704-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T07:35:53Z","timestamp":1634024153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-020-04704-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4704"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04704-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"12 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Wohlrab hat f\u00fcr Vortr\u00e4ge, Beratungsleistungen, f\u00fcr wissenschaftliche Projekte und f\u00fcr die Durchf\u00fchrung klinischer Studien von der Pfizer Pharma GmbH finanzielle Zuwendungen erhalten. A.\u00a0Maksimow und D.\u00a0Stintzing geben keine Interessenkonflikte an.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die Verwendung des Bildmaterials in diesem Manuskript liegt eine schriftliche Einwilligung der Patientin vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}